Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 2
2000 2
2001 1
2002 1
2003 1
2004 2
2005 1
2006 5
2007 1
2008 1
2009 2
2010 2
2011 1
2012 2
2013 1
2014 1
2015 1
2016 2
2019 4
2020 3
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
The Impact of Surgery on the Survival of Patients with Recurrent Glioblastoma.
Sacko O, Benouaich-Amiel A, Brandicourt P, Niaré M, Charni S, Cavandoli C, Brauge D, Catalaa I, Brenner A, Moyal EC, Roux FE. Sacko O, et al. Among authors: catalaa i. Asian J Neurosurg. 2021 Feb 23;16(1):1-7. doi: 10.4103/ajns.AJNS_180_20. eCollection 2021 Jan-Mar. Asian J Neurosurg. 2021. PMID: 34211860 Free PMC article.
What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
Bellanger G, Biotti D, Patsoura S, Ciron J, Ferrier M, Gramada R, Meluchova Z, Lerebours F, Catalaa I, Dumas H, Cognard C, Brassat D, Bonneville F. Bellanger G, et al. Among authors: catalaa i. Clin Neuroradiol. 2020 Sep;30(3):553-558. doi: 10.1007/s00062-019-00794-0. Epub 2019 May 29. Clin Neuroradiol. 2020. PMID: 31143968
Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
Roques M, Catalaa I, Raveneau M, Attal J, Siegfried A, Darcourt J, Cognard C, de Champfleur NM, Bonneville F. Roques M, et al. Among authors: catalaa i. PLoS One. 2022 Oct 13;17(10):e0270216. doi: 10.1371/journal.pone.0270216. eCollection 2022. PLoS One. 2022. PMID: 36227862 Free PMC article.
Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia.
Siegfried A, Masliah-Planchon J, Roux FE, Larrieu-Ciron D, Pierron G, Nicaise Y, Gambart M, Catalaa I, Péricart S, Dubucs C, Mohand-Oumoussa B, Tirode F, Bourdeaut F, Uro-Coste E. Siegfried A, et al. Among authors: catalaa i. Acta Neuropathol Commun. 2019 Dec 30;7(1):220. doi: 10.1186/s40478-019-0870-8. Acta Neuropathol Commun. 2019. PMID: 31888756 Free PMC article. No abstract available.
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A. Khalifa J, et al. Among authors: catalaa i. J Neurooncol. 2016 Oct;130(1):181-192. doi: 10.1007/s11060-016-2232-8. Epub 2016 Aug 8. J Neurooncol. 2016. PMID: 27502603
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme.
Moyal EC, Laprie A, Delannes M, Poublanc M, Catalaa I, Dalenc F, Berchery D, Sabatier J, Bousquet P, De Porre P, Alaux B, Toulas C. Moyal EC, et al. Among authors: catalaa i. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1396-401. doi: 10.1016/j.ijrobp.2007.02.043. Epub 2007 Jun 14. Int J Radiat Oncol Biol Phys. 2007. PMID: 17570606 Clinical Trial.
38 results